Net Cash Provided by (Used in) Operating Activities |
-51K |
USD |
-122% |
Dec 31, 2022 |
2022 |
Common Stock, Shares Authorized |
25M |
shares |
0% |
Dec 31, 2022 |
Q4 2022 |
Common Stock, Shares, Issued |
5.32M |
shares |
0% |
Dec 31, 2022 |
Q4 2022 |
Common Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Dec 31, 2022 |
Q4 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-51K |
USD |
-122% |
Dec 31, 2022 |
2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
7K |
USD |
-87.9% |
Dec 31, 2022 |
Q4 2022 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
-100% |
Dec 31, 2022 |
Q4 2022 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2022 |
2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
0 |
USD |
-100% |
Dec 31, 2022 |
Q4 2022 |
Preferred Stock, Shares Issued |
2M |
shares |
0% |
Dec 31, 2022 |
Q4 2022 |
Preferred Stock, Shares Authorized |
5M |
shares |
0% |
Dec 31, 2022 |
Q4 2022 |
Additional Paid in Capital |
13.5M |
USD |
0% |
Dec 31, 2022 |
Q4 2022 |
Preferred Stock, Shares Outstanding |
2M |
shares |
0% |
Dec 31, 2022 |
Q4 2022 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Dec 31, 2022 |
Q4 2022 |
Interest Expense |
1.49M |
USD |
+3.34% |
Dec 31, 2022 |
2022 |
Preferred Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Dec 31, 2022 |
Q4 2022 |